Last update 21 Nov 2024

Clogestone acetate

Last update 21 Nov 2024

Overview

R&D Status

Clinical Result

Translational Medicine

Overview

Basic Info

Drug Type

Hormone

Synonyms

Chlormadinol acetate

Target

Mechanism

PR agonists(Progesterone receptor agonists)

Therapeutic Areas-

Active Indication-

Inactive Indication-

Originator Organization-

Active Organization-

Inactive Organization-

Drug Highest Phase-

First Approval Date-

Regulation-

Structure

Molecular FormulaC25H33ClO5

InChIKeyKSCZWFXQKITHSL-OKCNGXCSSA-N

CAS Registry3044-32-4

100 Clinical Results associated with Clogestone acetate

100 Translational Medicine associated with Clogestone acetate

100 Patents (Medical) associated with Clogestone acetate

Literatures (Medical) associated with Clogestone acetate

01 Sep 1992·Die PharmazieQ4 · MEDICINE

Molecular modelling studies on the digitalis binding site of the Na+/K(+)-ATPase.

Q4 · MEDICINE

Article

Author: Anzali, S ; Höltje, H D

Using molecular modelling methods, several digitalis-unlike compounds such as chlormadinol acetate and cassaine, which bind to the digitalis receptor and inhibit the Na+/K(+)-ATPase were compared with cardenolides as a standard. The interaction energies of this group of compounds with various probes such as a methyl group or a NH-amid group were calculated using GRID and compared using GRAD. A pharmacophore model was derived, which describes all corresponding inotropic substrates. On this basis and including experimental knowledge on the Na+/K(+)-ATPase a receptor model was developed.

01 Jan 1990·Reproduction, Fertility and DevelopmentQ4 · BIOLOGY

Artificial insemination of Cashmere goats: effects on fertility and fecundity of intravaginal treatment, method and time of insemination, semen freezing process, number of motile spermatozoa and age of females

Q4 · BIOLOGY

Article

Author: Ritar, A J ; O'May, P J ; Ball, P D

The experiments, using a total of 1833 Cashmere does, were conducted to examine the effects on fertility and fecundity of intravaginal treatment for control of ovulation, time of insemination by cervical and laparoscopic methods, semen processing in pellets and straws, and number of frozen-thawed motile spermatozoa. Adult does (greater than or equal to 2.5 years) that had previously kidded were inseminated into the cervix, and maiden (kid: 6-8 months; hogget: 18 months) and adult does were inseminated laparoscopically. The rates of pregnancy determined by ultrasonic scanning (75-80 days after insemination) for cervical (Experiment 1) and laparoscopic (Experiments 2 and 3) insemination were 39.1%, 63.6% and 52.1%. The number of motile spermatozoa did not affect fertility after cervical (80, 120 and 160 x 10(6) or laparoscopic (Experiment 2: 15, 30 and 60 x 10(6); Experiment 3:5, 10 and 20 x 10(6) insemination. The method of insemination or number of motile spermatozoa did not affect fecundity. With cervical insemination, fertility and fecundity improved with increasing depth of insemination into the reproductive tract. Intravaginal sponges containing fluorogestone acetate and controlled internal drug release (CIDR) devices containing progesterone were equally effective for control of ovulation when combined with an injection of pregnant mare's serum gonadotrophin (PMSG; 200 i.u.) before insemination. Fertility was higher when does were inseminated before than after ovulation. After laparoscopic insemination, results were similar for semen frozen as pellets and in straws, and for 3-, 6- and 24-fold pre-freezing dilution of semen. For kid, hogget and adult does in Experiment 3, pregnancy rates were 34.0%, 55.4% and 63.9% and rates of fecundity were 1.17, 1.22 and 1.27 fetuses/pregnant doe.

01 Feb 1989·TheriogenologyQ2 · AGRICULTURAL & FORESTRY SCIENCE

Clinical use of Norgestomet ear implants or intravaginal pessaries for synchronization of estrus in anestrous dairy goats

Q2 · AGRICULTURAL & FORESTRY SCIENCE

Article

Author: N. Madrid ; K.N. Bretzlaff

Ear implants that contained 3 mg Norgestomet or vaginal pessaries that contained 40 or 45 mg fluorogestone acetate were used to induce estrus in dairy goats in three herds in May. Ear implants or vaginal pessaries were left in place for 11 d. Cloprostenol (50 mug) and PMSG (500 IU) were administered i.m. 24 h prior to removal of ear implants or vaginal pessaries. After removal of vaginal pessaries, onset of standing estrus occurred in 22 23 goats (96%) at 20 +/- 4.7 h, in 19 20 goats (95%) at 22 +/- 6.3 h, and in 16 16 goats (100%) at 19 +/- 1.2 h in Herds A, B and C, respectively. After removal of ear implants, onset of standing estrus occurred in 25 25 goats (100%) at 19 +/- 4.9 h, in 20 22 goats (91%) at 22 +/- 7.0 h, and in 15 15 goats (100%) at 18 +/- 2.2 h in Herds A, B and C, respectively. Does were bred by natural service in Herds A and B, and by artificial insemination 28 h after vaginal pessary or ear implant removal in Herd C. Pregnancy rates were determined 39 to 53 d post breeding by real-time ultrasound. Pregnancy rates in goats with vaginal pessaries were 32, 55 and 6%; and in goats with ear implants they were 56, 67 and 27% in Herds A, B and C, respectively. Problems encountered included poor libido in some bucks, abortions in undersized yearling does, and loss of ear implants by three does (not included in the data). Statistically there was no difference in pregnancy rates between goats receiving vaginal pessaries or ear implants (P>0.10).

100 Deals associated with Clogestone acetate

External Link

KEGG	Wiki	ATC	Drug Bank
-	Clogestone acetate	-	-

R&D Status

Clinical Result

Indication

Phase

Evaluation

View All Results

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Deal

Boost your decision using our deal data.

view full example data

Core Patent

Boost your research with our Core Patent data.

view full example data

Clinical Trial

Identify the latest clinical trials across global registries.

view full example data

Approval

Accelerate your research with the latest regulatory approval information.

view full example data

Regulation

Understand key drug designations in just a few clicks with Synapse.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis